These small cap ASX shares are ending the week on a high

The Australian share market has given back its strong morning gains and has sunk into the red this afternoon.

Three small cap shares that haven’t let that hold them back are listed below. Here’s why they are storming higher on Friday:

The Amaysim Australia Ltd (ASX: AYS) share price has rocketed 12% higher to $1.15 after the telco company announced the sale of its broadband business. Amaysim has entered into an asset sale deed with Southern Phone Company Ltd to sell its fixed line broadband customer base for a purchase price of approximately $3 million. Investors appear pleased with the sale of the loss-making segment. In FY 2017 it posted an operating loss of $2.6 million and then last year this increased to an operating loss of $6.3 million.

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has risen 3.5% to 5.6 cents following the release of the cannabis company’s quarterly report. Although the company posted little by way of cash receipts, investors appear to have reacted well to its outlook. Management advised that it has made strong progress across multiple fronts during the quarter, validating its seed-to-pharma strategy and signalling the start of commercialisation for CannEpil product in Australia. It is now focused squarely on continuing to build out its pharma operations, including the construction of the company’s facility in Malta.

The Titomic Ltd (ASX: TTT) share price has pushed 4.5% higher to $1.65. This morning the metal additive manufacturing company announced a $2.6 million Innovative Manufacturing Cooperative Research Centre program which aims to standardise its Kinetic Fusion product. The project will focus on enhancing the product as a transformational technology for the highest standards of aerospace and defence industries as outlined by The Metallic Materials Properties Development and Standardisation. This is a widely accepted source for metallic materials and recognised by the U.S. Federal Aviation Administration, Department of Defence and NASA.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!